Trump signed an executive order Monday directing ACIP to cut the routine childhood vaccine schedule from 17 to 11. Six vaccines — RSV, hepatitis A, hepatitis B, dengue, meningococcal ACWY and B — shift from universal to high-risk-only or shared clinical decision-making. ACIP has 90 days to publish a side-by-side OECD peer comparison. The order also mandates breaking up the MMR into separate shots.
1
Six Vaccines Off the Routine List
Six vaccines exit the universal schedule: RSV, hepatitis A, hepatitis B, dengue, meningococcal ACWY and B. Pharma stocks fell immediately: GSK -4.1%, Sanofi -3.3%, Merck -3.8%, Pfizer -2.6%. RSV and hepatitis A vaccines represent 17–19% of GSK's and Sanofi's total revenue respectively — the deepest exposed names.
2
MMR Split and the Science Problem
The order cites autism concerns despite decades of peer-reviewed evidence finding no causal link. ACIP's statutory independence is preserved but its work is now framed within the HHS scientific assessment. The split-MMR requirement adds clinical visit friction that will suppress uptake among lower-income families. APA procedural challenge expected within 30 days.
3
Execution Risk: States Are Not Bound
Most states maintain independent school-entry vaccine mandates not preempted by federal executive order. The 90-day ACIP comparison report is the real mechanism: if it shows the US schedule exceeds OECD median doses, political pressure shifts to state legislatures. Without that report, the federal order changes no one's actual vaccination requirement.
The executive order sets the frame. The 90-day ACIP comparison report is where this fight actually happens.
Sources
- ✓ White House — Delivering Gold Standard Childhood Vaccine Recommendations — August 10 2026
- ✓ CNN — Trump signs executive order aimed at reducing childhood vaccines — August 10 2026
- ✓ NBC News — Trump order aims to cut diseases vaccinated against from 18 to 11 — August 10 2026
#VaccinePolicy#RFKJr#ACIP#ChildhoodVaccines